Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
3.550
-0.170 (-4.57%)
At close: Mar 28, 2025, 4:00 PM
3.749
+0.199 (5.61%)
After-hours: Mar 28, 2025, 7:56 PM EDT
Lantern Pharma Market Cap
Lantern Pharma has a market cap or net worth of $38.29 million as of March 28, 2025. Its market cap has decreased by -48.88% in one year.
Market Cap
38.29M
Enterprise Value
14.52M
1-Year Change
-48.88%
Ranking
Category
Stock Price
$3.55
Market Cap Chart
Since June 11, 2020, Lantern Pharma's market cap has increased from $30.33M to $38.29M, an increase of 26.23%. That is a compound annual growth rate of 4.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 38.29M | 11.29% |
| Dec 31, 2024 | 34.40M | -26.05% |
| Dec 29, 2023 | 46.52M | -29.06% |
| Dec 30, 2022 | 65.58M | -26.55% |
| Dec 31, 2021 | 89.28M | -25.41% |
| Dec 31, 2020 | 119.69M | 294.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |